Abstract Details

Title Primary Efficacy and Safety of Istradefylline (KW-6002) in Levodopa-Treated Parkinson's Disease Patients with Motor Response Complications: Results of the KW-6002-US-013 Study

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 023

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��